Share Price and Basic Stock Data
Last Updated: October 14, 2025, 9:24 pm
| PEG Ratio | 3.07 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Mastek Ltd operates in the IT Consulting and Software industry, showcasing a robust growth trajectory in its revenue. For the fiscal year ending March 2025, Mastek reported sales of ₹3,455 Cr, which indicates a significant increase from ₹2,563 Cr in March 2023. The quarterly sales figures also reflect this upward trend, with the latest quarter (June 2025) recording sales of ₹915 Cr, up from ₹709 Cr in March 2023. This consistent growth is underpinned by a strong demand for digital transformation services, particularly in the UK market, where Mastek has a notable presence. However, while the sales growth is commendable, the operating profit margin (OPM) has shown a declining trend, standing at 15% for the latest reported period, down from 18% in March 2023. The company’s ability to sustain revenue growth amidst fluctuating margins will be critical as it navigates an increasingly competitive landscape.
Profitability and Efficiency Metrics
Mastek’s profitability metrics reflect a mixed performance, with net profit for the fiscal year 2025 reported at ₹376 Cr, a decline from ₹310 Cr in the previous year. The earnings per share (EPS) also saw a slight reduction, standing at ₹121.50 compared to ₹95.99 in March 2023. Despite these challenges, the company’s return on equity (ROE) was reported at 16.1%, while the return on capital employed (ROCE) stood at 17.3%. These figures indicate that Mastek is still generating reasonable returns on its equity and capital investments. Furthermore, the interest coverage ratio (ICR) is robust at 11.80x, suggesting that the company can comfortably meet its interest obligations. However, the cash conversion cycle (CCC) of 78 days indicates room for improvement in working capital management. Balancing profitability with operational efficiency will be essential for Mastek to enhance shareholder value in the long run.
Balance Sheet Strength and Financial Ratios
Mastek’s balance sheet reflects a solid financial position, characterized by total reserves of ₹2,447 Cr against borrowings of ₹583 Cr. This results in a debt-to-equity ratio of 0.23, indicating prudent financial leverage compared to industry norms. The company’s current ratio is reported at 1.42, suggesting sufficient liquidity to cover short-term liabilities, while the quick ratio also stands at 1.42, further reinforcing its liquidity position. Additionally, the price-to-book value ratio is at 3.75x, which may suggest that the stock is trading at a premium relative to its book value. The company’s asset turnover ratio has improved to 0.89%, indicating more efficient use of its assets to generate sales. However, the trend of increasing operational expenses, which rose to ₹2,909 Cr in March 2025 from ₹2,108 Cr in March 2023, could pose a risk to future profitability if not controlled.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Mastek Ltd reveals a diverse ownership structure, with promoters holding 35.96% of the equity, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold 11.05% and 10.52%, respectively. Public shareholders constitute 42.47%, indicating a healthy level of retail participation. Over the recent quarters, promoter holdings have gradually declined from 37.28% in September 2022 to the current 35.96%, which may raise concerns regarding insider confidence. Conversely, FIIs have increased their stake from 13.04% to 11.05% in the same timeframe, suggesting growing institutional interest in the company. The total number of shareholders has decreased significantly from 1,10,445 in September 2022 to 98,013 in June 2025, reflecting a potential consolidation in ownership. This shift could be perceived as a risk, as decreasing retail participation may affect liquidity and market perception.
Outlook, Risks, and Final Insight
If Mastek can manage its operational expenses effectively while maintaining revenue growth, it may enhance its profitability and shareholder returns in the future. The company’s strong interest coverage ratio and solid balance sheet provide a buffer against potential economic downturns. However, risks remain, particularly concerning declining net profits and margins, which could impact investor sentiment. Additionally, the shift in shareholding dynamics, with a decline in promoter holdings and fluctuating retail participation, might create volatility in stock performance. If Mastek continues to innovate and adapt to the evolving IT landscape, it could leverage its strengths in digital transformation to capture further market share. Overall, the company’s ability to strike a balance between growth and profitability will be crucial for sustaining investor confidence and achieving long-term success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Mastek Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | 0.39/0.33 | 1.12 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 27.9 Cr. | 8.82 | 10.2/4.43 | 0.25 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 179 Cr. | 166 | 194/99.8 | 39.9 | 33.2 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 35.6 Cr. | 278 | 310/140 | 27.6 | 19.0 | 0.36 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 6.49 Cr. | 1.34 | 1.73/0.91 | 59.0 | 2.52 | 0.00 % | 2.14 % | 2.15 % | 2.00 |
| Industry Average | 18,970.39 Cr | 560.74 | 142.87 | 118.21 | 0.53% | 14.92% | 20.95% | 6.84 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 570 | 625 | 659 | 709 | 725 | 766 | 784 | 780 | 813 | 867 | 870 | 905 | 915 |
| Expenses | 461 | 518 | 545 | 584 | 598 | 642 | 651 | 655 | 689 | 724 | 729 | 767 | 777 |
| Operating Profit | 109 | 107 | 114 | 126 | 127 | 123 | 134 | 125 | 124 | 143 | 141 | 139 | 137 |
| OPM % | 19% | 17% | 17% | 18% | 18% | 16% | 17% | 16% | 15% | 16% | 16% | 15% | 15% |
| Other Income | 26 | 32 | 6 | -0 | 2 | 1 | 3 | 5 | 4 | 17 | 13 | -5 | 11 |
| Interest | 2 | 5 | 8 | 9 | 9 | 13 | 13 | 9 | 9 | 11 | 12 | 10 | 9 |
| Depreciation | 11 | 17 | 20 | 20 | 20 | 21 | 22 | 27 | 20 | 20 | 17 | 19 | 18 |
| Profit before tax | 122 | 117 | 92 | 96 | 100 | 90 | 102 | 94 | 99 | 129 | 126 | 106 | 121 |
| Tax % | 31% | 27% | 27% | 25% | 27% | 28% | 24% | -1% | 28% | 0% | 25% | 23% | 24% |
| Net Profit | 84 | 86 | 67 | 73 | 74 | 65 | 78 | 94 | 72 | 129 | 95 | 81 | 92 |
| EPS in Rs | 25.68 | 26.30 | 21.33 | 23.77 | 22.91 | 20.50 | 24.56 | 29.85 | 23.18 | 41.68 | 30.67 | 26.20 | 29.75 |
Last Updated: August 1, 2025, 5:20 pm
Below is a detailed analysis of the quarterly data for Mastek Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 915.00 Cr.. The value appears strong and on an upward trend. It has increased from 905.00 Cr. (Mar 2025) to 915.00 Cr., marking an increase of 10.00 Cr..
- For Expenses, as of Jun 2025, the value is 777.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 767.00 Cr. (Mar 2025) to 777.00 Cr., marking an increase of 10.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 137.00 Cr.. The value appears to be declining and may need further review. It has decreased from 139.00 Cr. (Mar 2025) to 137.00 Cr., marking a decrease of 2.00 Cr..
- For OPM %, as of Jun 2025, the value is 15.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00%.
- For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from -5.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 16.00 Cr..
- For Interest, as of Jun 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 18.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 19.00 Cr. (Mar 2025) to 18.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 121.00 Cr.. The value appears strong and on an upward trend. It has increased from 106.00 Cr. (Mar 2025) to 121.00 Cr., marking an increase of 15.00 Cr..
- For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Mar 2025) to 24.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 92.00 Cr.. The value appears strong and on an upward trend. It has increased from 81.00 Cr. (Mar 2025) to 92.00 Cr., marking an increase of 11.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 29.75. The value appears strong and on an upward trend. It has increased from 26.20 (Mar 2025) to 29.75, marking an increase of 3.55.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:23 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 923 | 1,013 | 527 | 560 | 817 | 1,033 | 1,071 | 1,722 | 2,184 | 2,563 | 3,055 | 3,455 | 3,557 |
| Expenses | 833 | 965 | 509 | 515 | 718 | 902 | 916 | 1,357 | 1,721 | 2,108 | 2,546 | 2,909 | 2,997 |
| Operating Profit | 90 | 47 | 18 | 45 | 100 | 132 | 156 | 364 | 463 | 456 | 509 | 546 | 560 |
| OPM % | 10% | 5% | 3% | 8% | 12% | 13% | 15% | 21% | 21% | 18% | 17% | 16% | 16% |
| Other Income | 11 | 14 | 15 | 12 | 21 | 25 | 17 | 28 | 36 | 64 | 12 | 30 | 36 |
| Interest | 1 | 1 | 0 | 4 | 6 | 6 | 4 | 8 | 8 | 25 | 44 | 42 | 41 |
| Depreciation | 33 | 37 | 16 | 15 | 19 | 17 | 25 | 45 | 43 | 67 | 90 | 75 | 73 |
| Profit before tax | 68 | 22 | 16 | 39 | 96 | 133 | 144 | 339 | 448 | 427 | 386 | 459 | 481 |
| Tax % | 24% | 20% | 17% | 17% | 27% | 24% | 21% | 26% | 26% | 27% | 19% | 18% | |
| Net Profit | 52 | 18 | 14 | 32 | 70 | 101 | 114 | 252 | 333 | 310 | 311 | 376 | 396 |
| EPS in Rs | 23.37 | 7.86 | 5.97 | 13.86 | 29.53 | 42.33 | 44.82 | 82.97 | 98.32 | 95.99 | 97.36 | 121.50 | 128.30 |
| Dividend Payout % | 19% | 32% | 42% | 25% | 20% | 20% | 18% | 17% | 19% | 20% | 20% | 19% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -65.38% | -22.22% | 128.57% | 118.75% | 44.29% | 12.87% | 121.05% | 32.14% | -6.91% | 0.32% | 20.90% |
| Change in YoY Net Profit Growth (%) | 0.00% | 43.16% | 150.79% | -9.82% | -74.46% | -31.41% | 108.18% | -88.91% | -39.05% | 7.23% | 20.58% |
Mastek Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 26% |
| 3 Years: | 17% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 25% |
| 3 Years: | 9% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 29% |
| 3 Years: | 11% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 20% |
| 3 Years: | 17% |
| Last Year: | 16% |
Last Updated: Unknown
Balance Sheet
Last Updated: September 10, 2025, 2:04 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 12 | 12 | 12 | 12 | 12 | 13 | 15 | 15 | 15 | 15 |
| Reserves | 549 | 585 | 308 | 457 | 537 | 704 | 778 | 846 | 1,056 | 1,668 | 2,072 | 2,447 |
| Borrowings | 2 | 29 | 0 | 66 | 70 | 70 | 335 | 273 | 203 | 404 | 519 | 583 |
| Other Liabilities | 192 | 207 | 108 | 170 | 202 | 179 | 763 | 1,146 | 1,193 | 1,024 | 1,045 | 803 |
| Total Liabilities | 754 | 832 | 428 | 705 | 821 | 966 | 1,888 | 2,277 | 2,467 | 3,111 | 3,652 | 3,848 |
| Fixed Assets | 261 | 279 | 66 | 180 | 179 | 167 | 857 | 807 | 841 | 1,740 | 1,950 | 1,818 |
| CWIP | 0 | 1 | 0 | 0 | 2 | 1 | 2 | 2 | 4 | 7 | 1 | 2 |
| Investments | 84 | 54 | 50 | 274 | 284 | 396 | 276 | 234 | 26 | 69 | 94 | 178 |
| Other Assets | 409 | 498 | 312 | 251 | 356 | 401 | 754 | 1,235 | 1,596 | 1,296 | 1,607 | 1,851 |
| Total Assets | 754 | 832 | 428 | 705 | 821 | 966 | 1,888 | 2,277 | 2,467 | 3,111 | 3,652 | 3,848 |
Below is a detailed analysis of the balance sheet data for Mastek Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,447.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,072.00 Cr. (Mar 2024) to 2,447.00 Cr., marking an increase of 375.00 Cr..
- For Borrowings, as of Mar 2025, the value is 583.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 519.00 Cr. (Mar 2024) to 583.00 Cr., marking an increase of 64.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 803.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,045.00 Cr. (Mar 2024) to 803.00 Cr., marking a decrease of 242.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 3,848.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,652.00 Cr. (Mar 2024) to 3,848.00 Cr., marking an increase of 196.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1,818.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,950.00 Cr. (Mar 2024) to 1,818.00 Cr., marking a decrease of 132.00 Cr..
- For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Mar 2025, the value is 178.00 Cr.. The value appears strong and on an upward trend. It has increased from 94.00 Cr. (Mar 2024) to 178.00 Cr., marking an increase of 84.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,851.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,607.00 Cr. (Mar 2024) to 1,851.00 Cr., marking an increase of 244.00 Cr..
- For Total Assets, as of Mar 2025, the value is 3,848.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,652.00 Cr. (Mar 2024) to 3,848.00 Cr., marking an increase of 196.00 Cr..
Notably, the Reserves (2,447.00 Cr.) exceed the Borrowings (583.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 88.00 | 18.00 | 18.00 | -21.00 | 30.00 | 62.00 | -179.00 | 91.00 | 260.00 | 52.00 | -10.00 | -37.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 46 | 48 | 67 | 55 | 78 | 74 | 108 | 79 | 73 | 72 | 67 | 78 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 46 | 48 | 67 | 55 | 78 | 74 | 108 | 79 | 73 | 72 | 67 | 78 |
| Working Capital Days | 26 | 25 | 38 | 29 | 15 | 38 | 4 | -35 | -20 | 34 | -1 | 28 |
| ROCE % | 12% | 5% | 3% | 10% | 17% | 19% | 16% | 26% | 32% | 23% | 18% | 17% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Technology Fund | 250,560 | 0.51 | 55.34 | 250,560 | 2025-04-22 15:57:38 | 0% |
| Tata Digital India Fund | 155,070 | 0.43 | 36.82 | 155,070 | 2025-04-22 15:57:38 | 0% |
| Nippon India Nifty Smallcap 250 Index Fund | 9,532 | 0.27 | 2.26 | 9,532 | 2025-04-22 15:57:38 | 0% |
| Motilal Oswal Nifty Smallcap 250 Index Fund | 5,824 | 0.27 | 1.38 | 5,824 | 2025-04-22 15:57:38 | 0% |
| SBI Nifty Smallcap 250 Index Fund | 4,560 | 0.27 | 1.08 | 4,560 | 2025-04-22 15:56:55 | 0% |
| Quantum Small Cap Fund | 2,071 | 1.71 | 0.49 | 2,071 | 2025-04-22 15:56:55 | 0% |
| Motilal Oswal Nifty 500 Index Fund | 633 | 0.03 | 0.15 | 633 | 2025-04-22 15:56:55 | 0% |
| Edelweiss Nifty Smallcap 250 Index Fund | 239 | 0.27 | 0.06 | 239 | 2025-04-22 15:56:55 | 0% |
| Groww Nifty Total Market Index Fund | 42 | 0.02 | 0.01 | 42 | 2025-04-22 15:57:38 | 0% |
| Motilal Oswal Nifty 500 ETF | 27 | 0.02 | 0.01 | 27 | 2025-04-22 15:56:55 | 0% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 98.01 | 97.23 | 106.52 | 84.92 | 45.21 |
| Diluted EPS (Rs.) | 97.25 | 95.53 | 106.52 | 81.88 | 42.93 |
| Cash EPS (Rs.) | 129.99 | 123.74 | 125.35 | 117.55 | 57.13 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 676.85 | 581.42 | 406.96 | 336.32 | 303.06 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 676.85 | 581.42 | 406.96 | 336.32 | 303.06 |
| Revenue From Operations / Share (Rs.) | 990.53 | 839.90 | 727.46 | 682.19 | 441.30 |
| PBDIT / Share (Rs.) | 170.13 | 161.91 | 166.09 | 155.46 | 81.00 |
| PBIT / Share (Rs.) | 140.98 | 139.83 | 151.81 | 137.65 | 70.75 |
| PBT / Share (Rs.) | 125.22 | 140.03 | 149.25 | 134.44 | 59.34 |
| Net Profit / Share (Rs.) | 100.83 | 101.66 | 111.07 | 99.74 | 46.87 |
| NP After MI And SOA / Share (Rs.) | 97.37 | 96.01 | 98.31 | 82.94 | 44.84 |
| PBDIT Margin (%) | 17.17 | 19.27 | 22.83 | 22.78 | 18.35 |
| PBIT Margin (%) | 14.23 | 16.64 | 20.86 | 20.17 | 16.03 |
| PBT Margin (%) | 12.64 | 16.67 | 20.51 | 19.70 | 13.44 |
| Net Profit Margin (%) | 10.17 | 12.10 | 15.26 | 14.62 | 10.62 |
| NP After MI And SOA Margin (%) | 9.83 | 11.43 | 13.51 | 12.15 | 10.15 |
| Return on Networth / Equity (%) | 14.38 | 17.40 | 27.54 | 17.93 | 13.44 |
| Return on Capital Employeed (%) | 16.75 | 17.74 | 27.85 | 22.21 | 11.97 |
| Return On Assets (%) | 8.14 | 9.32 | 11.86 | 9.11 | 5.72 |
| Long Term Debt / Equity (X) | 0.15 | 0.15 | 0.11 | 0.16 | 0.29 |
| Total Debt / Equity (X) | 0.23 | 0.22 | 0.17 | 0.16 | 0.38 |
| Asset Turnover Ratio (%) | 0.89 | 0.18 | 0.17 | 0.16 | 0.24 |
| Current Ratio (X) | 1.42 | 1.69 | 1.78 | 1.87 | 1.85 |
| Quick Ratio (X) | 1.42 | 1.69 | 1.78 | 1.87 | 1.85 |
| Dividend Payout Ratio (NP) (%) | 19.39 | 19.59 | 16.10 | 6.50 | 28.91 |
| Dividend Payout Ratio (CP) (%) | 14.92 | 15.93 | 14.06 | 5.35 | 23.53 |
| Earning Retention Ratio (%) | 80.61 | 80.41 | 83.90 | 93.50 | 71.09 |
| Cash Earning Retention Ratio (%) | 85.08 | 84.07 | 85.94 | 94.65 | 76.47 |
| Interest Coverage Ratio (X) | 11.80 | 19.99 | 64.92 | 48.44 | 54.33 |
| Interest Coverage Ratio (Post Tax) (X) | 8.09 | 12.53 | 44.41 | 32.08 | 39.09 |
| Enterprise Value (Cr.) | 7924.50 | 4956.73 | 9576.73 | 2360.43 | 479.67 |
| EV / Net Operating Revenue (X) | 2.59 | 1.93 | 4.39 | 1.37 | 0.44 |
| EV / EBITDA (X) | 15.10 | 10.03 | 19.21 | 6.02 | 2.44 |
| MarketCap / Net Operating Revenue (X) | 2.56 | 1.83 | 4.56 | 1.79 | 0.42 |
| Retention Ratios (%) | 80.60 | 80.40 | 83.89 | 93.49 | 71.08 |
| Price / BV (X) | 3.75 | 2.79 | 9.30 | 2.64 | 0.56 |
| Price / Net Operating Revenue (X) | 2.56 | 1.83 | 4.56 | 1.79 | 0.42 |
| EarningsYield | 0.03 | 0.06 | 0.02 | 0.06 | 0.23 |
After reviewing the key financial ratios for Mastek Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 98.01. This value is within the healthy range. It has increased from 97.23 (Mar 23) to 98.01, marking an increase of 0.78.
- For Diluted EPS (Rs.), as of Mar 24, the value is 97.25. This value is within the healthy range. It has increased from 95.53 (Mar 23) to 97.25, marking an increase of 1.72.
- For Cash EPS (Rs.), as of Mar 24, the value is 129.99. This value is within the healthy range. It has increased from 123.74 (Mar 23) to 129.99, marking an increase of 6.25.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 676.85. It has increased from 581.42 (Mar 23) to 676.85, marking an increase of 95.43.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 676.85. It has increased from 581.42 (Mar 23) to 676.85, marking an increase of 95.43.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 990.53. It has increased from 839.90 (Mar 23) to 990.53, marking an increase of 150.63.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 170.13. This value is within the healthy range. It has increased from 161.91 (Mar 23) to 170.13, marking an increase of 8.22.
- For PBIT / Share (Rs.), as of Mar 24, the value is 140.98. This value is within the healthy range. It has increased from 139.83 (Mar 23) to 140.98, marking an increase of 1.15.
- For PBT / Share (Rs.), as of Mar 24, the value is 125.22. This value is within the healthy range. It has decreased from 140.03 (Mar 23) to 125.22, marking a decrease of 14.81.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 100.83. This value is within the healthy range. It has decreased from 101.66 (Mar 23) to 100.83, marking a decrease of 0.83.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 97.37. This value is within the healthy range. It has increased from 96.01 (Mar 23) to 97.37, marking an increase of 1.36.
- For PBDIT Margin (%), as of Mar 24, the value is 17.17. This value is within the healthy range. It has decreased from 19.27 (Mar 23) to 17.17, marking a decrease of 2.10.
- For PBIT Margin (%), as of Mar 24, the value is 14.23. This value is within the healthy range. It has decreased from 16.64 (Mar 23) to 14.23, marking a decrease of 2.41.
- For PBT Margin (%), as of Mar 24, the value is 12.64. This value is within the healthy range. It has decreased from 16.67 (Mar 23) to 12.64, marking a decrease of 4.03.
- For Net Profit Margin (%), as of Mar 24, the value is 10.17. This value exceeds the healthy maximum of 10. It has decreased from 12.10 (Mar 23) to 10.17, marking a decrease of 1.93.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.83. This value is within the healthy range. It has decreased from 11.43 (Mar 23) to 9.83, marking a decrease of 1.60.
- For Return on Networth / Equity (%), as of Mar 24, the value is 14.38. This value is below the healthy minimum of 15. It has decreased from 17.40 (Mar 23) to 14.38, marking a decrease of 3.02.
- For Return on Capital Employeed (%), as of Mar 24, the value is 16.75. This value is within the healthy range. It has decreased from 17.74 (Mar 23) to 16.75, marking a decrease of 0.99.
- For Return On Assets (%), as of Mar 24, the value is 8.14. This value is within the healthy range. It has decreased from 9.32 (Mar 23) to 8.14, marking a decrease of 1.18.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.15. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.15.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.23. This value is within the healthy range. It has increased from 0.22 (Mar 23) to 0.23, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.89. It has increased from 0.18 (Mar 23) to 0.89, marking an increase of 0.71.
- For Current Ratio (X), as of Mar 24, the value is 1.42. This value is below the healthy minimum of 1.5. It has decreased from 1.69 (Mar 23) to 1.42, marking a decrease of 0.27.
- For Quick Ratio (X), as of Mar 24, the value is 1.42. This value is within the healthy range. It has decreased from 1.69 (Mar 23) to 1.42, marking a decrease of 0.27.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 19.39. This value is below the healthy minimum of 20. It has decreased from 19.59 (Mar 23) to 19.39, marking a decrease of 0.20.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 14.92. This value is below the healthy minimum of 20. It has decreased from 15.93 (Mar 23) to 14.92, marking a decrease of 1.01.
- For Earning Retention Ratio (%), as of Mar 24, the value is 80.61. This value exceeds the healthy maximum of 70. It has increased from 80.41 (Mar 23) to 80.61, marking an increase of 0.20.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 85.08. This value exceeds the healthy maximum of 70. It has increased from 84.07 (Mar 23) to 85.08, marking an increase of 1.01.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 11.80. This value is within the healthy range. It has decreased from 19.99 (Mar 23) to 11.80, marking a decrease of 8.19.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 8.09. This value is within the healthy range. It has decreased from 12.53 (Mar 23) to 8.09, marking a decrease of 4.44.
- For Enterprise Value (Cr.), as of Mar 24, the value is 7,924.50. It has increased from 4,956.73 (Mar 23) to 7,924.50, marking an increase of 2,967.77.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.59. This value is within the healthy range. It has increased from 1.93 (Mar 23) to 2.59, marking an increase of 0.66.
- For EV / EBITDA (X), as of Mar 24, the value is 15.10. This value exceeds the healthy maximum of 15. It has increased from 10.03 (Mar 23) to 15.10, marking an increase of 5.07.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.56. This value is within the healthy range. It has increased from 1.83 (Mar 23) to 2.56, marking an increase of 0.73.
- For Retention Ratios (%), as of Mar 24, the value is 80.60. This value exceeds the healthy maximum of 70. It has increased from 80.40 (Mar 23) to 80.60, marking an increase of 0.20.
- For Price / BV (X), as of Mar 24, the value is 3.75. This value exceeds the healthy maximum of 3. It has increased from 2.79 (Mar 23) to 3.75, marking an increase of 0.96.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.56. This value is within the healthy range. It has increased from 1.83 (Mar 23) to 2.56, marking an increase of 0.73.
- For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 23) to 0.03, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mastek Ltd:
- Net Profit Margin: 10.17%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.75% (Industry Average ROCE: 14.92%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.38% (Industry Average ROE: 20.95%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.09
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.42
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.8 (Industry average Stock P/E: 142.87)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.23
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.17%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 804/805, President House, Opp. C N Vidyalaya, Ahmedabad Gujarat 380006 | investor_grievances@mastek.com http://www.mastek.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashank Desai | Chairman, Non Ind & Non Exe Director |
| Mr. Umang Nahata | WholeTime Director & CEO |
| Mr. Ketan Mehta | Non Exe.Non Ind.Director |
| Mr. Suresh Vaswani | Ind. Non-Executive Director |
| Mr. Rajeev Kumar Grover | Ind. Non-Executive Director |
| Ms. Marilyn Jones | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Mastek Ltd?
Mastek Ltd's intrinsic value (as of 14 October 2025) is 1741.02 which is 18.07% lower the current market price of 2,125.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹6,582 Cr. market cap, FY2025-2026 high/low of 3,375/1,883, reserves of ₹2,447 Cr, and liabilities of 3,848 Cr.
What is the Market Cap of Mastek Ltd?
The Market Cap of Mastek Ltd is 6,582 Cr..
What is the current Stock Price of Mastek Ltd as on 14 October 2025?
The current stock price of Mastek Ltd as on 14 October 2025 is 2,125.
What is the High / Low of Mastek Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mastek Ltd stocks is 3,375/1,883.
What is the Stock P/E of Mastek Ltd?
The Stock P/E of Mastek Ltd is 16.8.
What is the Book Value of Mastek Ltd?
The Book Value of Mastek Ltd is 796.
What is the Dividend Yield of Mastek Ltd?
The Dividend Yield of Mastek Ltd is 1.08 %.
What is the ROCE of Mastek Ltd?
The ROCE of Mastek Ltd is 17.3 %.
What is the ROE of Mastek Ltd?
The ROE of Mastek Ltd is 16.1 %.
What is the Face Value of Mastek Ltd?
The Face Value of Mastek Ltd is 5.00.